Erythropoietin down-regulates stem cell factor receptor (Kit) expression in the leukemic proerythroblast: Role of Lyn kinase

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Kosmider, Olivier ^a,b   Buet, Dorothée ^a,b   Gallais, Isabelle ^a,b   Denis, Nicole ^a,b   Moreau Gachelin, Françoise ^a,b  

^a INSTITUT CURIE   (France)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; PROTEIN KINASE LYN; STEM CELL FACTOR RECEPTOR; CYTOKINE; LYN PROTEIN-TYROSINE KINASE; MUTANT PROTEIN; ONCOPROTEIN; PROTEIN TYROSINE KINASE; PROTO ONCOGENE PROTEIN SPI 1; PROTO-ONCOGENE PROTEIN SPI-1; STAT5 PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ERYTHROBLAST; ERYTHROLEUKEMIA CELL; ERYTHROPOIESIS; GROWTH INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; ENZYMOLOGY; LEUKEMIA; METABOLISM;

MUS;

ANIMALS; CELL LINE; CELL PROLIFERATION; CYTOKINES; DOWN-REGULATION; ERYTHROBLASTS; ERYTHROPOIETIN; LEUKEMIA; MICE; MUTANT PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, ERYTHROPOIETIN; SRC-FAMILY KINASES; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 66449113965     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005721     Document Type: Article

References (54)

1. Munugalavadla V, Kapur R (2005) Role of c-Kit and erythropoietin receptor in erythropoiesis. Crit Rev Oncol Hematol 54: 63-75.
2. Nocka K, Majumder S, Chabot B, Ray P, Cervone M, et al. (1989) Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice-evidence for an impaired c-kit kinase in mutant mice. Genes Dev 3: 816-826.
3. Geissler EN, Ryan MA, Housman DE (1988) The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 55: 185-192.
4. Wu H, Liu X, Jaenisch R, Lodish HF (1995) Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83: 59-67.
5. Katayama N, Shih JP, Nishikawa S, Kina T, Clark SC, et al. (1993) Stage-specific expression of c-kit protein by murine hematopoietic progenitors. Blood 82: 2353-2360.
6. Uoshima N, Ozawa M, Kimura S, Tanaka K, Wada K, et al. (1995) Changes in c-Kit expression and effects of SCF during differentiation of human erythroid progenitor cells. Br J Haematol 91: 30-36.
7. Fraser JK, Lin FK, Berridge MV (1988) Expression of high affinity receptors for erythropoietin on human bone marrow cells and on the human erythroleukemic cell line, HEL. Exp Hematol 16: 836-842.
8. Wognum AW, Lansdorp PM, Humphries RK, Krystal G (1990) Detection and isolation of the erythropoietin receptor using biotinylated erythropoietin. Blood 76: 697-705.
9. Moreau-Gachelin F, Wendling F, Molina T, Denis N, Titeux M, et al. (1996) Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol 16: 2453-2463.
10. Iwasaki H, Somoza C, Shigematsu H, Duprez EA, Iwasaki-Arai J, et al. (2005) Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106: 1590-1600.
11. Dakic A, Metcalf D, Di Rago L, Mifsud S, Wu L, et al. (2005) PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med 201: 1487-1502.
12. McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, et al. (1996) Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. Embo J 15: 5647-5658.
13. Scott EW, Fisher RC, Olson MC, Kehrli EW, Simon MC, et al. (1997) PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity 6: 437-447.
14. Rimmele P, Kosmider O, Mayeux P, Moreau-Gachelin F, Guillouf C (2007) Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation. Blood 109: 3007-3014.
15. Guillemin K, Krasnow MA (1997) The hypoxic response: huffing and HIFing. Cell 89: 9-12.
16. Barnache S, Mayeux P, Payrastre B, Moreau-Gachelin F (2001) Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi- 1/PU.1 transgenic proerythroblasts. Blood 98: 2372-2381.
17. Casteran N, De Sepulveda P, Beslu N, Aoubala M, Letard S, et al. (2003) Signal transduction by several KIT juxtamembrane domain mutations. Oncogene 22: 4710-4722.
18. Kosmider O, Denis N, Lacout C, Vainchenker W, Dubreuil P, et al. (2005) Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in mice. Cancer Cell 8: 467-478.
19. Gouilleux F, Pallard C, Dusanter-Fourt I, Wakao H, Haldosen LA, et al. (1995) Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. Embo J 14: 2005-2013.
20. Wakao H, Harada N, Kitamura T, Mui AL, Miyajima A (1995) Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. Embo J 14: 2527-2535.
21. Tan BL, Hong L, Munugalavadla V, Kapur R (2003) Functional and biochemical consequences of abrogating the activation of multiple diverse early signaling pathways in Kit. Role for Src kinase pathway in Kit-induced cooperation with erythropoietin receptor. J Biol Chem 278: 11686-11695.
22. Tilbrook PA, Ingley E, Williams JH, Hibbs ML, Klinken SP (1997) Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells. Embo J 16: 1610-1619.
23. Broudy VC, Lin NL, Liles WC, Corey SJ, O'Laughlin B, et al. (1999) Signaling via Src family kinases is required for normal internalization of the receptor c-Kit. Blood 94: 1979-1986.
24. Jahn T, Seipel P, Coutinho S, Urschel S, Schwarz K, et al. (2002) Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domain. Oncogene 21: 4508-4520.
25. Panterne B, Hatzfeld A, Sansilvestri P, Cardoso A, Monier MN, et al. (1996) IL-3, GM-CSF and CSF-1 modulate c-fms mRNA more rapidly in human early monocytic progenitors than in mature or transformed monocytic cells. J Cell Sci 109 (Pt 7): 1795-1801.
26. Muta K, Krantz SB, Bondurant MC, Dai CH (1995) Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood 86: 572-580.
27. Munugalavadla V, Dore LC, Tan BL, Hong L, Vishnu M, et al. (2005) Repression of c-kit and its downstream substrates by GATA-1 inhibits cell proliferation during erythroid maturation. Mol Cell Biol 25: 6747-6759.
28. Yee NS, Hsiau CW, Serve H, Vosseller K, Besmer P (1994) Mechanism of down-regulation of c-kit receptor. Roles of receptor tyrosine kinase, phosphatidylinositol 3′-kinase, and protein kinase C. J Biol Chem 269: 31991-31998.
29. Miyazawa K, Toyama K, Gotoh A, Hendrie PC, Mantel C, et al. (1994) Ligand-dependent polyubiquitination of c-kit gene product: a possible mechanism of receptor down modulation in M07e cells. Blood 83: 137-145.
30. Kozlowski M, Larose L, Lee F, Le DM, Rottapel R, et al. (1998) SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain. Mol Cell Biol 18: 2089-2099.
31. Vitelli L, Condorelli G, Lulli V, Hoang T, Luchetti L, et al. (2000) A pentamer transcriptional complex including tal-1 and retinoblastoma protein down-modulates c-kit expression in normal erythroblasts. Mol Cell Biol 20: 5330-5342.
32. Jing H, Vakoc CR, Ying L, Mandat S, Wang H, et al. (2008) Exchange of GATA factors mediates transitions in looped chromatin organization at a developmentally regulated gene locus. Mol Cell 29: 232-242.
33. Wu H, Klingmuller U, Besmer P, Lodish HF (1995) Interaction of the erythropoietin and stem-cell-factor receptors. Nature 377: 242-246.
34. Wu H, Klingmuller U, Acurio A, Hsiao JG, Lodish HF (1997) Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation. Proc Natl Acad Sci USA 94: 1806-1810.
35. Jacobs-Helber SM, Penta K, Sun Z, Lawson A, Sawyer ST (1997) Distinct signaling from stem cell factor and erythropoietin in HCD57 cells. J Biol Chem 272: 6850-6853.
36. Panzenbock B, Bartunek P, Mapara MY, Zenke M (1998) Growth and differentiation of human stem cell factor/erythropoietin- dependent erythroid progenitor cells in vitro. Blood 92: 3658-3668.
37. von Lindern M, Zauner W, Mellitzer G, Steinlein P, Fritsch G, et al. (1999) The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood 94: 550-559.
38. Kapur R, Zhang L (2001) A novel mechanism of cooperation between c-Kit and erythropoietin receptor. Stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin. J Biol Chem 276: 1099-1106.
39. Li K, Miller C, Hegde S, Wojchowski D (2003) Roles for an Epo receptor Tyr-343 Stat5 pathway in proliferative co-signaling with kit. J Biol Chem 278: 40702-40709.
40. Sato T, Watanabe S, Ishii E, Tsuji K, Nakahata T (1998) Induction of the erythropoietin receptor gene and acquisition of responsiveness to erythropoietin by stem cell factor in HML/SE, a human leukemic cell line. J Biol Chem 273: 16921-16926.
41. Waskow C, Terszowski G, Costa C, Gassmann M, Rodewald HR (2004) Rescue of lethal c-KitW/W mice by erythropoietin. Blood 104: 1688-1695.
42. Harder KW, Parsons LM, Armes J, Evans N, Kountouri N, et al. (2001) Gain-and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage. Immunity 15: 603-615.
43. Harder KW, Quilici C, Naik E, Inglese M, Kountouri N, et al. (2004) Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1. Blood 104: 3901-3910.
44. Karur VG, Lowell CA, Besmer P, Agosti V, Wojchowski DM (2006) Lyn kinase promotes erythroblast expansion and late-stage development. Blood 108: 1524-1532.
45. Tilbrook PA, Palmer GA, Bittorf T, McCarthy DJ, Wright MJ, et al. (2001) Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn. Cancer Res 61: 2453-2458.
46. Chin H, Arai A, Wakao H, Kamiyama R, Miyasaka N, et al. (1998) Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway. Blood 91: 3734-3745.
47. Penta K, Sawyer ST (1995) Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells. J Biol Chem 270: 31282-31287.
48. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, et al. (1993) JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74: 227-236.
49. Kubota Y, Tanaka T, Kitanaka A, Ohnishi H, Okutani Y, et al. (2001) Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase. Embo J 20: 5666-5677.
50. Okutani Y, Kitanaka A, Tanaka T, Kamano H, Ohnishi H, et al. (2001) Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway. Oncogene 20: 6643-6650.
51. Brizzi MF, Dentelli P, Rosso A, Yarden Y, Pegoraro L (1999) STAT protein recruitment and activation in c-Kit deletion mutants. J Biol Chem 274: 16965-16972.
52. Pircher TJ, Geiger JN, Zhang D, Miller CP, Gaines P, et al. (2001) Integrative signaling by minimal erythropoietin receptor forms and c-Kit. J Biol Chem 276: 8995-9002.
53. Arcasoy MO, Jiang X (2005) Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor. Br J Haematol 130: 121-129.
54. Menon MP, Karur V, Bogacheva O, Bogachev O, Cuetara B, et al. (2006) Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis. J Clin Invest 116: 683-694.